Further, these and other signaling mechanisms identified (e.g., TGFβ signaling, EMT) may also broaden the role of CRP in regulating processes critical to neoplastic development, metastasis, recurrence, and treatment resistance in cancer. The gene discussed is TGFB1; the disease is cancer.